Johnson & Johnson (J&J) has reported more data supporting the efficacy of its intravesical drug release system TAR-200 in patients with Bacillus Calmette-Guérin (BCG)-unresponsive, high-risk ...

Silo Pharma, Inc. announced a service agreement with Resyca BV to conduct a drug-device study on its microchip-based nasal spray system for SPC-15, an intranasal treatment for PTSD. This study aims to ...

Inspired by a hitchhiking fish that uses a specialized suction organ to latch onto sharks and other marine animals, researchers from MIT and other institutions have designed a mechanical adhesive ...

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the ...

“Washington bureaucracy and regulations far too often interfere with health care decisions of patients and their doctors,” said Sen. Ted Cruz (R-TX) in joining forces with Rep. Chip Roy (R-TX) to ...